Literature DB >> 15723721

Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2.

Yoko Tanimura1, Toshio Kokuryo, Nobuyuki Tsunoda, Yukiko Yamazaki, Koji Oda, Yuji Nimura, Naing Naing Mon, Pengyu Huang, Yasuni Nakanuma, Min-Fu Chen, Yi-Yin Jan, Ta-Sen Yeh, Cheng-Taug Chiu, Ling-Ling Hsieh, Michinari Hamaguchi.   

Abstract

We studied the effect of TNF-alpha stimulation on a cholangiocarcinoma cell line, CCKS1. CCKS1 expressed only one type TNF receptor, TNFR2. Treatment of CCKS1 with TNF-alpha substantially activated NFkappaB, MAPK and Akt signalings which in turn activated matrix metalloproteinase-9 (MMP-9) secretion and in vitro invasiveness of CCKS1. Pretreatment of cells with anti-TNFR2 neutralizing antibody inhibited the TNF-alpha-dependent signaling and MMP-9 secretion and subsequently blocked invasion in vitro. Moreover, an inhibitor for matrix metalloproteinase, Galardin, suppressed the invasion in a dose-dependent manner. Similarly, pharmacological inhibition of signaling clearly suppressed the TNF-alpha dependent MMP-9 secretion. These results strongly suggest that TNF-alpha-TNFR2 signaling plays an important role to convert the cholangiocarcinoma cells to be more aggressive one.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723721     DOI: 10.1016/j.canlet.2004.07.027

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  Clinical implications of tumor necrosis factor receptor 2 in breast cancer.

Authors:  Fuqian Yang; Zhonghua Zhao; Nana Zhao
Journal:  Oncol Lett       Date:  2017-06-19       Impact factor: 2.967

2.  Tumor necrosis factor receptor 2 may promote the proliferation and drug resistance of Kapras299 and L428 lymphoma cells via the AKT and WNT/β-catenin signaling pathways.

Authors:  Yanyan Liang; Yu Wang; Meng Xiao; Yunliang Hao; Yongtian Zhang; Shumei Li
Journal:  Oncol Lett       Date:  2018-03-30       Impact factor: 2.967

3.  Tumor necrosis factor receptor 2 promotes growth of colorectal cancer via the PI3K/AKT signaling pathway.

Authors:  Tao Zhao; Huihui Li; Zifeng Liu
Journal:  Oncol Lett       Date:  2016-11-21       Impact factor: 2.967

4.  The Role of cIAP1 and XIAP in Apoptosis Induced by Tumor Necrosis Factor Alpha in Esophageal Squamous Cell Carcinoma Cells.

Authors:  Shoichiro Hikami; Atsushi Shiozaki; Maki Kitagawa-Juge; Daisuke Ichikawa; Toshiyuki Kosuga; Hirotaka Konishi; Shuhei Komatsu; Hitoshi Fujiwara; Kazuma Okamoto; Eigo Otsuji
Journal:  Dig Dis Sci       Date:  2017-01-03       Impact factor: 3.199

Review 5.  Obesity and cholangiocarcinoma.

Authors:  Mansour A Parsi
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

6.  Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.

Authors:  Anchalee Techasen; Nisana Namwat; Watcharin Loilome; Pornpan Bungkanjana; Narong Khuntikeo; Anucha Puapairoj; Patcharee Jearanaikoon; Hideyuki Saya; Puangrat Yongvanit
Journal:  Med Oncol       Date:  2012-08-19       Impact factor: 3.064

7.  Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha.

Authors:  Keita Itatsu; Motoko Sasaki; Junpei Yamaguchi; Shusaku Ohira; Akira Ishikawa; Hiroko Ikeda; Yasunori Sato; Kenichi Harada; Yoh Zen; Hiroshi Sato; Tetsuo Ohta; Masato Nagino; Yuji Nimura; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

8.  Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion.

Authors:  Kawin Leelawat; Surang Leelawat; Siriluck Narong; Suradej Hongeng
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

Review 9.  Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.

Authors:  Simone Brivio; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  Gene Expr       Date:  2017-10-25

10.  Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review.

Authors:  Gyem Tshering; Palden Wangyel Dorji; Wanna Chaijaroenkul; Kesara Na-Bangchang
Journal:  Am J Trop Med Hyg       Date:  2018-04-05       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.